ask="2.00"
ask_size="800"
average_daily_volume="558198"
bid="1.70"
bid_size="2700"
book_value="0.12"
change="+0.06"
change_from_200_day_moving_average="0.65"
change_from_50_day_moving_average="0.42"
change_from_52_week_high="-1.18"
change_From_52_week_low="1.38"
change_in_percent="+3.31%"
close="1.87"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.83"
ebitda="-21.56M"
eps_estimate_current_year="-0.81"
eps_estimate_next_quarter="-0.18"
eps_estimate_next_year="-0.87"
ex_dividend_date="N/A"
float_shares="18812000"
high="1.96"
high_52_weeks="3.05"
last_trade_date="3/14/2017"
last_trade_price="1.87"
last_trade_size="732"
last_trade_time="4:00pm"
low="1.78"
low_52_weeks="0.49"
market_capitalization="54.97M"
moving_average_200_day="1.22"
moving_average_50_day="1.45"
name="Galectin Therapeutics Inc."
notes="N/A"
one_year_target_price="1.12"
open="1.87"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+53.01%"
percent_change_from_50_day_moving_average="+29.22%"
percent_change_from_52_week_high="-38.69%"
percent_change_from_52_week_low="+281.63%"
previous_close="1.81"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="14.48"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="29396000"
short_ratio="2.30"
stock_exchange="NCM"
symbol="GALT"
volume="697680"
weeks_range_52="0.49 - 3.05"
